Evaluation of treatment response of chemoembolization in hepatocellular carcinoma with diffusion-weighted imaging on 3.0-T MR imaging

Journal of Vascular and Interventional Radiology

Volumn 23, Issue 2, 2012, Pages 241-247

  Sahin, Hilal ^a   Harman, Mustafa ^a   Cinar, Celal ^a   Bozkaya, Halil ^a   Parildar, Mustafa ^a   Elmas, Nevra ^a  

^a EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CHEMOEMBOLIZATION; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; FEMALE; HUMAN; LIVER CELL CARCINOMA; MALE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; TREATMENT RESPONSE; TUMOR VOLUME;

ADULT; AGED; ANTIBIOTICS, ANTINEOPLASTIC; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; DIFFUSION MAGNETIC RESONANCE IMAGING; DOXORUBICIN; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

EID: 84855997694     PISSN: 10510443     EISSN: 15357732     Source Type: Journal    
DOI: 10.1016/j.jvir.2011.08.030     Document Type: Article

References (24)

1. J.A. Vossen, M. Buijs, I.R. Kamel Assessment of tumor response on MR imaging after locoregional therapy Tech Vasc Intervent Radiol 9 2006 125 132 (Pubitemid 46875018)
2. I.R. Kamel, D.A. Bluemke Magnetic resonance imaging of the liver: assessing response to treatment Top Magn Reson Imaging 13 2002 191 200
3. J. Bruix, M. Sherman American Association for the Study of Liver Diseases Management of hepatocellular carcinoma: an update Hepatology 53 2011 1020 1022
4. J.F. Geschwind, D. Artemov, S. Abraham Chemoembolization of liver tumor in a rabbit model: assessment of tumor cell death with diffusion-weighted MR imaging and histologic analysis J Vasc Interv Radiol 11 2000 1245 1255
5. I.R. Kamel, D.A. Bluemke, D. Ramsey Role of diffusion weighted imaging in estimating tumor necrosis after chemoembolization of hepatocellular carcinoma AJR Am J Roentgenol 181 2003 708 710 (Pubitemid 37021839)
6. J.S. Yu, J.H. Kim, J.J. Chung, K.W. Kim Added value of diffusion-weighted imaging in the MRI assessment of perilesional tumor recurrence after chemoembolization of hepatocellular carcinomas J Magn Reson Imaging 30 2009 153 160
7. C.Y. Chen, C.W. Li, Y.T. Kuo Early response of hepatocellular carcinoma to transcatheter arterial chemoembolization: choline levels and MR diffusion constantsinitial experience Radiology 239 2006 448 456
8. T.L. Lu, R.A. Meuli, P.M. Marques-Vidal, P. Bize, A. Denys, S. Schmidt Interobserver and intraobserver variability of the apparent diffusion coefficient in treated malignant hepatic lesions on a 3.0T machine: measurements in the whole lesion versus in the area with the most restricted diffusion J Magn Reson Imaging 32 2010 647 653
9. J.M. Llovet, J. Fuster, J. Bruix The Barcelona Approach: diagnosis, staging and treatment of hepatocellular carcinoma Liver Transpl 10 2004 115 120
10. R. Lencioni, J.M. Llovet Modified RECIST (mRECIST) assessment for hepatocellular carcinoma Semin Liver Dis 30 2010 52 60
11. A. Forner, C. Ayuso, M. Varela Evaluation of tumor response after locoregional therapies in hepatocellular carcinoma Cancer 115 2009 616 623
12. J. Bruix, M. Sherman, J.M. Llovet Clinical management of hepatocellular carcinoma Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver J Hepatol 35 2001 421 430 (Pubitemid 32844200)
13. R.C. Semelka, S. Worawattanakul, M.A. Mauro, S.A. Bernard, W.G. Cance Malignant hepatic tumors: changes on MRI after hepatic arterial chemoembolization - preliminary findings J Magn Reson Imaging 8 1998 48 56 (Pubitemid 28099558)
14. Z. Yuan, X.D. Ye, S. Dong Role of magnetic resonance diffusion-weighted imaging in evaluating response after chemoembolization of hepatocellular carcinoma Eur J Radiol 75 2010 e9 e14
15. A. Thabet, S. Kalva, D.A. Gervais Percutaneous image-guided therapy of intraabdominal malignancy: imaging evaluation of treatment response Abdom Imaging 34 2008 593 609
16. Y.H. Yuan, E.H. Xiao, J.B. Liu Characteristics and pathological mechanism on magnetic resonance diffusion-weighted imaging after chemoembolization in rabbit liver VX-2 tumor model World J Gastroenterol 13 2007 5699 5706
17. I.R. Kamel, D.A. Bluemke, J. Eng The role of functional MR imaging in the assessment of tumor response after chemoembolization in patients with hepatocellular carcinoma J Vasc Interv Radiol 17 2006 505 512 (Pubitemid 44318722)
18. B. Taouli, D.M. Koh Diffusion-weighted MR imaging of the liver Radiology 254 2010 47 66
19. J.Y. Choi, M.J. Kim, Y.E. Chung Abdominal applications of 3.0-T MR imaging: comparative review versus a 1.5-T system Radiographics 28 2008 e30
20. S.M. Erturk, A. Alberich-Bayarri, K.A. Herrman, L. Marti-Bonmati, P.R. Ros Use of 3.0-T MR imaging for evaluation of the abdomen Radiographics 29 2009 1547 1563
21. S.T. Schindera, E.M. Merkle, B.M. Dale, D.M. Delong, R.C. Nelson Abdominal magnetic resonance imaging at 3.0 T what is the ultimate gain in signal-to-noise ratio? Acad Radiol 13 2006 1236 1243 (Pubitemid 44363166)
22. K.J. Chang, I.R. Kamel, K.J. Macura, D.A. Bluemke 3.0-T MR imaging of the abdomen: comparison with 1.5 T Radiographics 28 2008 1983 1998
23. O. Dietrich, M.F. Reiser, S.O. Schoenberg Artifacts in 3-T MRI: physical background and reduction strategies Eur J Radiol 65 2008 29 35
24. M.M. Barth, M.P. Smith, I. Pedrosa, R.E. Lenkinski, N.M. Rofsky Body MR imaging at 3.0 T: understanding the opportunities and challenges Radiographics 27 2007 1445 1464